Helus Pharma's total assets for Q4 2026 were C$251.99M, a decrease of -13.07% from the previous quarter. HELP total liabilities were C$19.44M for the fiscal quarter, a 20.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.